Neonatal Sepsis
Neonatal sepsis is a life-threatening infection in the first 28 days of life. NICE CG149 guides risk factor-based screening and empirical treatment with IV benzylpenicillin and gentamicin within 1 hour of suspicion.
Key Facts
- Early-onset neonatal sepsis (EONS): <72 hours; most commonly Group B Streptococcus (GBS) and E. coli
- Late-onset neonatal sepsis (LONS): 72 hours to 28 days; CoNS (in preterm with central lines), S. aureus, Gram-negatives, Candida
- NICE CG149: Risk factor-based approach - red flags (antibiotics for maternal sepsis, confirmed GBS with risk factors, signs of neonatal sepsis) require immediate treatment
- Empirical treatment: IV benzylpenicillin 25mg/kg + gentamicin 5mg/kg - start within 1 hour
- Signs are non-specific: Temperature instability, poor feeding, lethargy, respiratory distress, apnoeas, tachycardia, irritability, abdominal distension
- GBS is the most common cause of EONS in the UK - incidence ~0.5 per 1000 live births; UK does NOT routinely screen pregnant women (unlike USA)
- LP should be performed in all neonates with confirmed sepsis or strong suspicion of meningitis unless contraindicated
- Blood culture is the gold standard - but may take 24-48h to grow; treat empirically while awaiting
Overview
Key Facts
Neonatal sepsis remains a significant cause of neonatal mortality and morbidity. The non-specific nature of neonatal sepsis signs makes a high index of suspicion essential. NICE CG149 provides a structured approach based on risk factors and clinical indicators.
Epidemiology
EONS incidence: ~0.9 per 1,000 live births. GBS-EONS: ~0.5 per 1,000. LONS is more common in preterm infants, especially those with central venous lines. Neonatal sepsis mortality: ~5-10% for term infants, up to ~30% for very preterm.
Aetiology
Early-onset (<72h):
- Group B Streptococcus (GBS) - most common overall
- Escherichia coli - most common Gram-negative; leading cause in preterm EONS
- Listeria monocytogenes - uncommon but important (maternal food-borne)
Late-onset (72h-28 days):
- Coagulase-negative Staphylococci (CoNS) - most common in NICU (line-related)
- Staphylococcus aureus, E. coli, Klebsiella, Candida (very preterm)
Pathophysiology
Neonatal immune system is immature: reduced complement activity, low IgM and IgA (only maternal IgG crosses placenta), impaired neutrophil chemotaxis and opsonisation, and reduced T-cell function. This renders neonates highly susceptible to bacterial infection with rapid progression to septic shock and meningitis.
Clinical Presentation
Clinical Signs (Non-Specific)
- Temperature: Hypothermia (<36°C) or fever (>38°C); hypothermia more common in preterm
- Respiratory: Tachypnoea, grunting, apnoeas, increased O2 requirement
- Cardiovascular: Tachycardia, poor perfusion, hypotension (late sign)
- Neurological: Lethargy, irritability, poor feeding, seizures, bulging fontanelle
- GI: Feeding intolerance, abdominal distension, vomiting
- Skin: Mottling, pallor, petechiae, prolonged CRT
NICE CG149 Risk Factors for EONS
Red flags (treat immediately):
- Clinical signs of neonatal sepsis
- Suspected or confirmed maternal sepsis treated with IV antibiotics
- Maternal GBS colonisation + ONE of: preterm labour, PROM >18h, maternal fever >38°C
Non-red flag risk factors (observe ± treat):
- PROM >18h, maternal GBS colonisation (without additional risk factors), maternal pyrexia, gestational age <37 weeks
Red Flags
- Apnoeas - may be only sign of sepsis in preterm infants
- Seizures - suggests meningitis
- Rapidly deteriorating - fulminant sepsis/meningitis
- Purpura/petechiae - DIC, meningococcal (rare in neonates)
Differential Diagnosis
| Diagnosis | Key Features | Investigation |
|---|---|---|
| Neonatal sepsis | Risk factors + non-specific signs | Blood culture, FBC, CRP |
| Respiratory distress syndrome | Preterm, ground glass CXR, surfactant deficiency | CXR, blood gas |
| Congenital pneumonia | Prolonged rupture of membranes, respiratory distress | CXR, blood culture |
| Congenital heart disease | Cyanosis, murmur, poor feeding | Echocardiography |
| Metabolic disease | Lethargy, poor feeding, metabolic acidosis | Blood gas, ammonia, amino acids |
| Necrotising enterocolitis | Abdominal distension, bloody stools, pneumatosis | AXR |
Diagnosis / Investigation
Bedside
- Observations: Temperature, HR, RR, SpO2, BP, capillary refill
- Blood glucose: Hypoglycaemia common in sepsis
Bloods
- Blood culture: GOLD STANDARD - before antibiotics if possible (but do NOT delay antibiotics)
- FBC: WCC may be high, low, or normal; left shift (raised immature:total neutrophil ratio); thrombocytopenia
- CRP: May be normal initially; repeat at 18-24h (serial CRP is useful)
- Procalcitonin: Rising - more specific than CRP for bacterial infection
- Blood gas: Metabolic acidosis in severe sepsis
Imaging
- CXR: If respiratory symptoms - pneumonia, RDS
- AXR: If abdominal signs - NEC
Special Tests
- LP (CSF): For all confirmed sepsis or strong clinical suspicion of meningitis - cell count, protein, glucose, culture, PCR
- Urine MC&S: More relevant in LONS (clean catch or SPA)
- Surface swabs: Ear, umbilicus - may guide therapy but not diagnostic of invasive infection
Management
Pharmacological
EONS (<72h):
- IV benzylpenicillin 25mg/kg 12-hourly (term; 8-hourly if meningitis) + gentamicin 5mg/kg OD
- Start within 1 hour of decision to treat
- Duration: Stop at 36-48h if blood culture negative AND clinically well AND CRP not rising
- If culture positive or meningitis confirmed: Continue for 7-14 days (meningitis: 14-21 days depending on organism)
LONS (>72h):
- Flucloxacillin + gentamicin (or per local protocol if NICU-acquired - may need broader cover)
- Candida: Fluconazole or amphotericin B for very preterm infants
Meningitis:
- Extend to meningitis doses: Benzylpenicillin or cefotaxime 50mg/kg + gentamicin
- Duration: GBS meningitis 14 days; Gram-negative meningitis 21 days
Non-pharmacological
- IV access: Ensure reliable venous access
- Fluid resuscitation: 10-20mL/kg 0.9% NaCl bolus if signs of shock; may need inotropes
- Respiratory support: CPAP, IPPV as needed
- Monitoring: Continuous cardiorespiratory monitoring, fluid balance, blood glucose
- Nutritional support: May need parenteral nutrition if feeds withheld
Referral Criteria
- All unwell neonates - neonatal team assessment
- Meningitis - neonatal unit; may need neurosurgical input if complications
- Not responding to first-line antibiotics - microbiology/infectious disease input
- Preterm LONS - neonatal unit
Prognosis
- EONS (GBS) mortality: ~5-10% in term infants; higher in preterm
- Gram-negative EONS mortality: ~15-20%
- GBS meningitis: Mortality ~10%; long-term neurodevelopmental sequelae in ~50% of survivors
- LONS (CoNS): Low mortality (<5%) but associated with prolonged NICU stay
- CRP as guide: Serial CRP helps guide antibiotic duration; falling CRP supports stopping at 36-48h if culture negative
Other Relevant Information
NICE CG149 - Decision Framework
| Scenario | Action |
|---|---|
| Clinical signs of sepsis | Blood culture + antibiotics within 1h |
| Maternal IV antibiotics for sepsis | Blood culture + antibiotics within 1h |
| GBS + 1 risk factor | Blood culture + antibiotics within 1h |
| PROM >18h alone | Observe + check CRP at 12h (enhanced observation) |
| GBS alone (no other risk factors) | Enhanced observation for 12h |
Antibiotic Doses (Neonatal)
| Drug | Dose (term) | Frequency |
|---|---|---|
| Benzylpenicillin | 25mg/kg | 12-hourly (<7d); 6-hourly (>7d or meningitis) |
| Gentamicin | 5mg/kg | Once daily (adjust per levels) |
| Cefotaxime | 50mg/kg | 8-12 hourly |
| Flucloxacillin | 25-50mg/kg | 6-12 hourly |